1、Objective to explore effects of blood platelets and prothrombin time on mifepristone.
目的探討米非司酮對(duì)血小板、血漿凝血酶原時(shí)間的影響。

2、In contrast, there wag no abnormal prothrombin in the rat plasma during its liver regeneration.
誘癌早期的大鼠血漿即出現(xiàn)了高水平異常凝血酶原，它可用于肝癌的早期診斷。

3、Prothrombin G20210A mutation can lead to plasma prothrombin level increase.
凝血酶原基因g20210a突變，可導(dǎo)致血漿凝血酶原水平升高。

4、When the tissue damage, the release of thromboplastin to prothrombin into thrombin.
當(dāng)組織損傷時(shí)，釋放出凝血致活酶，把凝血酶原變成凝血酶。

5、Objective: to investigate the part influence factors of prothrombin time assay.
目的：探討凝血酶原時(shí)間測(cè)定的部分影響因素。

6、Conclusion Prothrombin 20210a gene mutation may increase genetic susceptibility of gastric cancer.
結(jié)論凝血酶原突變基因20210A可能增加了胃癌的遺傳易感性。

7、Studies on Abnormal Prothrombin in Rats With Hepatocellular Carcinoma
肝癌大鼠異常凝血酶原的研究

8、Results No prothrombin gene G20210A mutation was found in both patients and controls.
結(jié)果所有受檢者均未發(fā)現(xiàn)凝血酶原G20210A基因突變。

9、Used for biochemical studies, to prevent the prothrombin into thrombin.
用于生化研究，防止凝血酶原轉(zhuǎn)變成凝血酶。

10、Laboratory: increase Prothrombin time.
實(shí)驗(yàn)室檢查：凝血酶原時(shí)間(PT)延長(zhǎng)。

prothrombin翻譯

n. 凝血酶原【化】 凝血酶原; 凝血因子II【醫(yī)】 前凝血酶, 凝血酶原 詳情